Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Kanika Sehgal, Hind J Fadel, Aaron J Tande, Darrell S Pardi & Sahil Khanna. (2021) Outcomes in Patients with SARS-CoV-2 and Clostridioides difficile Coinfection. Infection and Drug Resistance 14, pages 1645-1648.
Read now
Read now
Dieter H. M. Gröschel & B. Toye. (1996) Clostridium difficile Infection. Critical Reviews in Clinical Laboratory Sciences 33:3, pages 203-245.
Read now
Read now
Articles from other publishers (15)
Miranda A. L. van Tilburg. 2017. Pediatric Neurogastroenterology. Pediatric Neurogastroenterology
71
80
.
Toru Otori, Sumio Matzno, Atushi Kawase, Masahiro Iwaki, Tetsutaro Kimachi, Keiji Nishiwaki, William C Figoni, Ryuta Tominaga, Mai Asahide, Mayumi Nishikata, Yoshikazu Ishii & Kenji Matsuyama. (2016) Development of hemiacetal esterified levofloxacin to prevent chelation with metal-containing drugs. Journal of Pharmacy and Pharmacology 68:12, pages 1527-1534.
Crossref
Crossref
Justyna Bien, Vindhya Palagani & Przemyslaw Bozko. (2012)
The intestinal microbiota dysbiosis and
Clostridium difficile
infection: is there a relationship with inflammatory bowel disease?
. Therapeutic Advances in Gastroenterology 6:1, pages 53-68.
Crossref
Crossref
Miranda A. L. van Tilburg. 2013. Pediatric Neurogastroenterology. Pediatric Neurogastroenterology
59
70
.
Camelia E. Marculescu, Elie F. Berbari, J. Robert Cantey & Douglas R. Osmon. (2012) Practical Considerations in the Use of Outpatient Antimicrobial Therapy for Musculoskeletal Infections. Mayo Clinic Proceedings 87:1, pages 98-105.
Crossref
Crossref
Jesse K. Liu & Gary R. Lichtenstein. 2012. Clinical Gastrointestinal Endoscopy. Clinical Gastrointestinal Endoscopy
243
264
.
S.M. Collins, E. Denou, E.F. Verdu & P. Bercik. (2009) The putative role of the intestinal microbiota in the irritable bowel syndrome. Digestive and Liver Disease 41:12, pages 850-853.
Crossref
Crossref
Stephen M. Collins & Premsyl Bercik. (2009) The Relationship Between Intestinal Microbiota and the Central Nervous System in Normal Gastrointestinal Function and Disease. Gastroenterology 136:6, pages 2003-2014.
Crossref
Crossref
T. Galpérine, F. Ader, P. Piriou, T. Judet, C. Perronne & L. Bernard. (2006) Antibiothérapie parentérale ambulatoire (APA), par voie intraveineuse dans les infections ostéoarticulaires. Médecine et Maladies Infectieuses 36:3, pages 132-137.
Crossref
Crossref
Mitchell S Cappell & David Friedel. (2002) The role of sigmoidoscopy and colonoscopy in the diagnosis and management of lower gastrointestinal disorders: endoscopic findings, therapy, and complications. Medical Clinics of North America 86:6, pages 1253-1288.
Crossref
Crossref
Joseph BertinoJr.Jr. & Douglas Fish. (2000) The safety profile of the fluoroquinolones. Clinical Therapeutics 22:7, pages 798-817.
Crossref
Crossref
Phillip M Williford. (1999) Opportunities for mupirocin calcium cream in the emergency department. The Journal of Emergency Medicine 17:1, pages 213-220.
Crossref
Crossref
MargaretL Hoffman-Terry, HenryS Fraimow, TimothyR Fox, BrianG Swift & JudithE Wolf. (1999) Adverse effects of outpatient parenteral antibiotic therapy. The American Journal of Medicine 106:1, pages 44-49.
Crossref
Crossref
Abdul B. Zafar, Larry A. Gaydos, William B. Furlong, Michelle H. Nguyen & Patricia A. Mennonna. (1998) Effectiveness of infection control program in controlling nosocomial Clostridium difficile. American Journal of Infection Control 26:6, pages 588-593.
Crossref
Crossref
S. E. Lowenkron, J. Waxner, P. Khullar, J. S. Ilowite, M. S. Niederman & A. M. Fein. (1996) Clostridium difficile infection as a cause of severe sepsis. Intensive Care Medicine 22:9, pages 990-994.
Crossref
Crossref